U

0001179350-12-000019.txt : 20120130 0001179350-12-000019.hdr.sgml : 20120130 20120127180521 ACCESSION NUMBER: 0001179350-12-000019 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20110930 FILED AS OF DATE: 20120130 DATE AS OF CHANGE: 20120127 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nano Mask, Inc. CENTRAL INDEX KEY: 0001088213 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 870561647 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-27421 FILM NUMBER: 12553002 BUSINESS ADDRESS: STREET 1: 50 WEST LIBERTY STREET, SUITE 880 CITY: RENO STATE: NV ZIP: 89501 BUSINESS PHONE: 209-275-9270 MAIL ADDRESS: STREET 1: 50 WEST LIBERTY STREET, SUITE 880 CITY: RENO STATE: NV ZIP: 89501 FORMER COMPANY: FORMER CONFORMED NAME: EMERGENCY FILTRATION PRODUCTS INC/ NV DATE OF NAME CHANGE: 19990608 10-Q 1 nanomask2011sep10qfinal.htm NANO MASK 11SEP 10Q U

U. S. SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

FORM 10-Q

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended: September 30, 2011

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period From ________ to_________

Commission File No. 000-27421

NANO MASK, INC.

(Exact Name of Small Business Issuer as Specified in its Charter)


NEVADA	87-0561647
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)


50 West Liberty Street, Suite 880, Reno, NV	89501
(Address of principal executive offices)	(Zip code)

Issuer's telephone number, including area code: (209) 275-9270

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. (1) Yes [ ] No [X] (2) Yes [X] No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ¨ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ¨ Accelerated filer ¨ Non-accelerated filer ¨ Smaller reporting company ý

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ Noý

State the number of shares outstanding of each of the issuer's classes of common equity, as of the latest practicable date:

At January 27, 2012, there were outstanding 84,742,347 shares of the Registrant's Common Stock, $.001 par value.

THIS QUARTERLY REPORT ON FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2011 IS BEING FILED SUBSTANTIALLY LATE, ON OR ABOUT JANUARY 27, 2012. SOME OF THE INFORMATION CONTAINED HEREIN REFERS TO HISTORICAL ACTIVITIES OF THE COMPANY FOR THE FISCAL PERIOD. SHAREHOLDER AND INVESTORS ARE ADVISED TO CONSULT THE COMPANY’S MORE RECENT FILINGS OF CURRENT REPORTS ON FORM 8-K AS WELL AS ADDITIONAL PERIODIC REPORTS FOR SUBSEQUENT PERIODS THAT THE COMPANY INTENDS TO FILE AS SOON AS POSSIBLE.

PART I

FINANCIAL INFORMATION


Table of Contents	Page

Part I Financial Information

Item 1. Financial Statements

Balance Sheets (Unaudited) as of September 30, 2011 and December 31, 2010	3

Statements of Operations (Unaudited) for the three and nine months ended September 30, 2011 and 2010	4

Statements of Cash Flows (Unaudited) for the nine months ended September 30, 2011 and 2010	5

Notes to the Financial Statements (Unaudited)	6

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations	8

Item 3. Quantitative and Qualitative Disclosures About Market Risk	10

Item 4. Controls and Procedures	10

Part II Other Information

Item 1. Legal Proceedings	11

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	11

Item 3. Defaults by the Company on its Senior Securities	11

Item 4. Submission of Matter to a Vote of Security Holders	11

Item 5. Other Information	11

Item 6. Exhibits	11

Signatures	12


NANO MASK, INC. Balance Sheets (Unaudited)
		September 30,	December 31,
		2011	2010
ASSETS

CURRENT ASSETS
	Cash	$ 4,835	$ 2,810
	Refund receivable	-	2,500
	Prepaid expenses	-	571
	Accounts receivable	650	-
	Inventory, net	74,404	14,421
		79,889	20,302

FIXED ASSETS
	Equipment	5,673	973
	Accumulated depreciation	(324)	(178)
		5,349	795

		$ 85,238	$ 21,097

LIABILITIES AND STOCKHOLDERS' DEFICIT

CURRENT LIABILITIES
	Customer advances	$ 70,130	$ -
	Accounts payable	548,579	759,512
	Accounts payable – related party	80,500	103,300
	Accrued expenses	340,663	343,497
	Notes payable	497,727	497,727
	Note payable – related party	25,000	-
		1,562,599	1,704,036

STOCKHOLDERS' DEFICIT

	Common stock, 100,000,000 shares authorized, $0.001 par value, 75,997,374 outstanding (75,526,952 issued and 470,422 issuable) and 57,979,351 (57,808,929 issued and 170,422 issuable) shares issued and outstanding	75,997	57,979
	Additional paid-in capital	20,935,804	20,427,452
	Accumulated deficit	(22,489,162)	(22,168,370)
	Stockholders’ deficit	(1,477,361)	(1,682,939)

		$ 85,238	$ 21,097

The accompanying notes are an integral part of these unaudited financial statements.


NANO MASK INC. Statements of Operations (Unaudited)
	For the Three Months Ended		For the Nine Months Ended
	September 30,		September 30,
	2011	2010	2011	2010

NET SALES	$ 1,888	$ -	$ 27,571	$ -

COSTS AND EXPENSES
Cost of sales	1,795	-	18,775	-
Research and development	3,400	-	3,400	68,550
Selling, general and administrative	276,609	115,078	673,400	524,511
	281,804	115,078	695,575	593,061

LOSS FROM OPERATIONS	(279,916)	(115,078)	(668,004)	(593,061)

OTHER INCOME (EXPENSE)
Gain on settlement of vendor liabilities and other	874	8,110	372,949	14,754
Interest expense	(8,634)	(8,751)	(25,737)	(25,581)
	(7,760)	(641)	347,212	(10,827)

NET LOSS	$ (287,676)	$ (115,719)	$ (320,792)	$ (603,888)
BASIC LOSS PER SHARE	$ (0.00)	$ (0.01)	$ (0.00)	$ (0.01)

WEIGHTED-AVERAGE NUMBER OF COMMON SHARES OUTSTANDING	73,952,578	50,679,307	67,787,590	53,950,933

The accompanying notes are an integral part of these unaudited financial statements.


NANO MASK INC. Statements of Cash Flows For the Nine Months Ended September 30, 2011 and 2010 (Unaudited)

			2011	2010

CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss			$ (320,792)	$ (603,888)
Adjustments to reconcile net loss to net cash
used in operating activities:
	Depreciation		146	130
	Common stock issued for services		331,200	83,850
	Common stock issued for company expenses incurred		12,170	27,737
	Gain on settlement of vendor liabilities		(372,949)	(14,754)
Changes in operating assets and liabilities:
	Accounts receivable		(650)	-
	Refund receivable		2,500	(2,500)
	Prepaid expenses		571	696
	Inventory		(59,983)	632
	Customer advances		70,130	-
	Accounts payable		292,216	31,278
	Accrued expenses		(2,834)	341,719
		Net cash used in operating activities	(48,275)	(135,100)

CASH FLOWS FROM INVESTING ACTIVITIES:
	Purchase of equipment		(4,700)	(973)
		Cash used in investing activities	(4,700)	(973)

CASH FLOWS FROM FINANCING ACTIVITIES:
	Common stock and warrants issued for cash		30,000	-
	Proceeds from the issuance of related party short-term note payable		25,000	-
	Proceeds from the issuance of short-term notes payable		-	6,855
	Repayments of short-term notes payable		-	(6,855)
		Cash provided by financing activities	55,000	-

NET INCREASE (DECREASE) IN CASH			2,025	(136,073)

CASH AT BEGINNING OF PERIOD			2,810	136,908

CASH AT END OF PERIOD			$ 4,835	$ 835

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid for interest			$ -	$ -
Cash paid for income taxes			$ -	$ -

NON-CASH INVESTING AND FINANCING ACTIVITIES
Accrued interest added to note payable balance			$ -	$ 12,620
Common stock issued for settlement of advances and accounts payable			$ 153,000	$ 10,000
The accompanying notes are an integral part of these unaudited financial statements.

NANO MASK, INC.

Notes to the Financial Statements (Unaudited)

For the Nine Months Ended September 30, 2011

NOTE 1 - BASIS OF PRESENTATION

The financial information included herein is unaudited and has been prepared consistent with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 8, Rule 8.03 of Regulation S-K. Accordingly, these financial statements do not include all information required by generally accepted accounting principles for annual financial statements. These statements should be read in conjunction with the audited financial statements and notes thereto included in the Company's annual report on Form 10-K for the year ended December 31, 2010, from which the balance sheet information as of that date is derived. These interim financial statements contain all adjustments necessary in the opinion of management for a fair statement of results for the interim periods presented.

The results of operations for the nine months ended September 30, 2011, are not necessarily indicative of the results to be expected for the full year.

Certain minor reclassifications in prior period amounts have been made to conform to the current period presentation.

NOTE 2 – GOING CONCERN

The Company’s financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. However, in addition to a working capital deficiency at September 30, 2011, the Company has incurred negative cash flow from operations and significant losses, which have substantially increased its operating deficit at September 30, 2011. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

The Company’s ability to continue as a going concern will be dependent upon economic developments and the success of management's plans as set forth below, which cannot be assured. The accompanying financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result from the outcome of this uncertainty. Management and board members are continuing to discuss other alternative financing options, but no definitive proposals or agreements have been reached.

The foregoing notwithstanding, management does not believe the Company currently has sufficient capital to sustain its planned business activities for the next twelve months following the issuance of these financial statements. Accordingly, while management has historically been successful generating sufficient funds to sustain operations, there is no assurance that they will continue to do so. Nevertheless, the Company will seek additional capital to sustain its operations, either through additional private placements of common stock or loans, possibly unsecured, until such time as its operations are self-sustaining. These funds will be required to continue the Company’s efforts to generate sales of its products and to provide sufficient working capital to meet the expected sales demand.

NOTE 3 –SIGNIFICANT TRANSACTIONS

The Company issued a short-term note payable of $25,000 to an affiliate with an annual interest rate of prime, plus 2%, payable in six months from February 22, 2011. Also, during the nine months ended September 30, 2011, the Company received cash advances of $106,500 from an executive officer with no specific repayment terms.

The following table summarizes the stock issuances during the nine months ended September 30, 2011:


Summary of Stock Issuances during the Nine Months ended September 30, 2011
Settlement of Advances and Payables			Settlement of Advances -Related Party			Compensation and Expenses		Cash Proceeds from Offerings
Common Shares	Fair Value	Carrying Value of Related Payables	Common Shares	Fair Value	Carrying Value of Related Advances	Common Shares	Fair Value	Common Shares	Cash
900,000	$24,300	$257,775	4,422,998	$129,300	$129,300	11,495,025	$342,957	1,200,000	$30,000

NANO MASK, INC.

Notes to the Financial Statements (Unaudited)

For the Nine Months Ended September 30, 2011

Due to the fair value of the common shares being less than the carrying value of the related payables, the Company recognized a gain on settlement of payables of $352,075 during the nine months ended September 30, 2011. An additional gain of $20,874 was generated by writing off payables due to the expiration of the statute of limitations.

NOTE 4 - SUBSEQUENT EVENTS

The following table summarizes the common shares issued subsequent to September 30, 2011 and their related amounts for cash proceeds from private placements offerings, stock-based compensation and expense reimbursements as well as settlement of loans payable:


Cash Proceeds from Offerings		Stock-Based Compensation and Expense Reimbursements		Settlement of Loans Payable
Common Shares	Amount	Common Shares	Amount	Common Shares	Amount
200,000	$5,000	7,544,973	$330,586	1,000,000	$60,000

NOTE 5 – CONTINGENCIES

On December 29, 2010, the Company received a complaint from Applied Nanoscience, Inc., seeking collection of the as yet unpaid notes payable to Applied in the amount of $453,500, plus interest and litigation expenses. On February 1, 2011, the Company countersued for breach of contract and related claims. The Company maintains a right of offset against Applied’s notes in the amount of $41,360 and is reflected on the balance sheet in the net amount of $412,140.

ITEM 2

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Cautionary Statement Regarding Forward-looking Statements

This report may contain "forward-looking" statements. Examples of forward-looking statements include, but are not limited to: (a) projections of revenues, capital expenditures, growth, prospects, dividends, capital structure and other financial matters; (b) statements of plans and objectives of our management or Board of Directors; (c) statements of our future economic performance; (d) statements of assumptions underlying other statements and statements about us and our business relating to the future; and (e) any statements using the words "anticipate," "expect," "may," "project," "intend" or similar expressions.

Overview

The Company is in the business of producing environmental masks and filters for medical devices that are designed to reduce the possibility of transmission of contagious diseases.

Since its inception, the Company has been involved in the development of its technology. Through September 30, 2011, revenues have not been adequate to cover operating expenses and thus, the Company has reported a loss in each of its years of existence. Through September 30, 2011, the Company has funded itself by way of a series of private equity placements and had offset its accumulated deficit in this manner.

Results of Operations for the Three Months Ended September 30, 2011 compared with 2010

Revenues: During the three months ended September 30, 2011 and 2010, there were revenues of approximately $2,000, compared to no revenues in 2010. Sales comprised four product-lines: Nano Zymes (15%) and Lab Coats (85%).

Cost of Sales: Cost of sales as a percentage of sales approximated 95% for the three months ended September 30, 2011.

Operating Expenses: During the three months ended September 30, 2011, the Company experienced a significant increase in general and administrative expenses of approximately $162,000 or approximately 140% compared to the three months ended September 30, 2010, primarily due to significant auditing fees in a concerted effort to establish current filings with the SEC.

Research and development: Research and development (R&D) relates to a new anti-viral and anti-bacterial mask, and includes related FDA testing in 2010. In 2011 such costs relate to testing of prospective third-party vendors. $3,400 was incurred in the three months ended September 30, 2011, compared to no such costs incurred in 2010. If resources are available in the future, the Company intends to bring additional products to market, assuming those products are still viable at the time the resources are available. The significant components of the Company’s research and development costs ordinarily include prototype development and materials, governmental filings and laboratory testing.

Results of Operations for the Nine Months Ended September 30, 2011 compared with 2010

Revenues: During the nine months ended September 30, 2011 and 2010, there were revenues of approximately $28,000, compared to no revenues in 2010. Sales comprised four product-lines: Vira Masks (20%),

Nano Zymes (16%), Lab Coats (62%) and other (2%).

Cost of Sales: Cost of sales as a percentage of sales approximated 68% for the nine months ended September 30, 2011.

Operating Expenses: During the nine months ended September 30, 2011, the Company experienced an increase in general and administrative expenses of approximately $149,000 or approximately 28% compared to the nine months ended September 30, 2010, primarily attributable to auditing fees of $279,000 in the nine months of 2011.

Research and development: Research and development relates to a new anti-viral and anti-bacterial mask, and includes related FDA testing. Such expenses increased marginally from the nine months ended September 30, 2009. Approximately $69,000 was incurred in the nine months ended September 30, 2010 on this new mask.

Liquidity and Capital Resources

The Company has not been able to generate sufficient net cash inflows from operations to sustain its business efforts and accommodate its growth plans. During the nine months 2011, the Company received cash advances from an executive officer for $106,500. Also, during the three months ended October 31, 2011, 1,400,000 shares of common stock were issued in a private placement to four individual investors for $35,000 in cash. Management and board members are continuing to discuss other alternative financing options, but no definitive proposals or agreements have been reached.

Beginning in the third quarter of 2008, the United States has been experiencing a severe and widespread recession accompanied by instability in the financial markets and reduced credit availability which are likely to continue to have far reaching effects on economic activity in the country for an indeterminate period. The effects and probable duration of these conditions and related risks and uncertainties on the Company's ability to obtain financing, success in its marketing efforts and ultimately, profitable operations and positive cash flows, cannot be estimated at this time.

The Company does not believe that it currently has sufficient capital to sustain its business efforts for the next twelve months. Accordingly, the Company will need to raise additional capital in the near future to sustain operations. The Company is also working on minimizing operating expenses, to the extent possible, by reducing overhead costs, salaries, and other consulting and professional fees, in order to conserve available cash.

Accordingly, for these and other reasons, there is significant uncertainty regarding the Company’s future, and the Company’s auditors expressed substantial doubt as to the Company’s ability to continue as a going concern in their report on the Company’s 2010 audited financial statements.

Impact of Inflation

At this time, the Company does not anticipate that inflation will have a material impact on current or future operations.

Critical Accounting Policies and Estimates

Except with regard to the estimated useful lives of patents and acquired technology, the net realizable value of the Company’s inventory due to shelf-life issues and design, the allowance for bad debts on accounts receivable, and the effective provision of a 100% deferred income tax asset valuation allowance, the Company does not employ any critical accounting policies or estimates that are either selected from among available alternatives or require the exercise of significant management judgment to apply or that if changed are likely to materially affect future periods.

Management reviews the carrying value of the technology assets annually based on its current marketing activities, plans and expectations, and the perceived effects of competitive factors and possible obsolescence, whether any write-downs should be taken or whether the estimated useful lives should be shortened.

Management also reviews the carrying value of its inventory periodically for evidence of declines in estimated fair value and considers, based on its current marketing activities, plans and expectations, and the perceived effects of competitive factors and possible obsolescence due to shelf-life issues on the environmental filters, whether any write-downs should be taken.

Management also reviews the collectability of outstanding receivables based upon historical collection history from each customer, the age of the receivables, and the customers wherewithal to pay the outstanding balance, and records an estimated allowance for bad debts sufficient to cover any potential losses to be incurred for non-collections.

Recent Accounting Pronouncements

While there have been Financial Accounting Standards Board (FASB) pronouncements made effective subsequent to the issuance of these financial statements, none would have required restatement of the financial statements herein nor have they had any significant effect on future financial statements of the Company.

ITEM 3

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Smaller reporting companies are not required to provide the information required by this item.

ITEM 4

CONTROLS AND PROCEDURES

We maintain a system of disclosure controls and procedures that are designed for the purpose of ensuring that information required to be disclosed in our SEC reports is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to the Company’s management, including the Chief Executive Officer and the Principal Accounting Officer, as appropriate to allow timely decisions regarding required disclosures.

For the period ended September 30, 2011, we carried out an evaluation, under the supervision and with the participation of our Chief Executive Officer and our Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rule 13a-15(e) or Rule 15d-15(e) under the Exchange Act. In the course of this evaluation, our management considered the material weakness in our internal control over financial reporting as discussed in our Annual Report on Form 10-K for the period ended December 31, 2010. Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that, as of the end of the period covered by this report on Form 10-Q, our disclosure controls and procedures were not effective to ensure that the information required to be disclosed by us in reports filed under the Securities Exchange Act of 1934 is (i) recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms and (ii) accumulated and communicated to the registrant’s management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding disclosure. To overcome this weakness, our principal executive and financial officers have reviewed and provided additional substantive accounting information and data in connection with the preparation of this quarterly report. Therefore, despite the weaknesses identified, our principal executive and financial officers believe that there are no material inaccuracies or omissions of material facts necessary to make the statements included in this report not misleading in light of the circumstances under which they are made.

Changes in Internal Control over Financial Reporting

We will continue to monitor and evaluate the effectiveness of our internal controls and procedures and our internal controls over financing reporting on an ongoing basis and are committed to taking further action and implementing additional enhancements or improvements, as necessary and as funds allow.

There have been no changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2011 that have materially affected, or were reasonably likely to materially affect, our internal control over financial reporting.

PART II

OTHER INFORMATION

ITEM 1 - LEGAL PROCEEDINGS

On December 29, 2010, the Company received a complaint from Applied Nanoscience, Inc., a Nevada corporation, filed in the District Court of Clark County in Nevada (Case No. A-10-631192-C) and which seeks collection of notes payable to Applied in the amount of $453,500, including accrued interest. On February 1, 2011, we countersued for breach of contract and claims related thereto. Our management believes that the value of its counterclaim will exceed the value of the claims asserted against the Company but cannot fully assess the outcome of the action at this time. Accordingly, management believes adequate provision has been made in the accompanying financial statements related to this complaint.

ITEM 2 - UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

During the three months ended October 31, 2011, 1,400,000 shares of common stock were issued in a private placement to four individual investors for $35,000 in cash.

These shares were issued in reliance on the exemption from registration and prospectus delivery requirements of the Act set forth in Section 3(b) and/or Section 4(2) of the Securities Act and the regulations promulgated hereunder.

ITEM 3 - DEFAULTS BY THE COMPANY ON ITS SENIOR SECURITIES

None

ITEM 4 - SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

None

ITEM 5 - OTHER INFORMATION

None

ITEM 6 – EXHIBITS


EXHIBIT NO.	DESCRIPTION

31	CERTIFICATION OF PRINCIPAL EXECUTIVE AND FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002.
31	CERTIFICATION OF PRINCIPAL EXECUTIVE AND FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002.
32	CERTIFICATION OF PRINCIPAL EXECUTIVE AND FINANCIAL OFFICER PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002.
32	CERTIFICATION OF PRINCIPAL EXECUTIVE AND FINANCIAL OFFICER PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002.
101.INS	XBRL INSTANCE DOCUMENT
101.SCH	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
101.CAL	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
101.DEF	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
101.LAB	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
101.PRE	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT

SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

NANO MASK, INC.

January 27, 2012

/s/ Edward Suydam

Edward Suydam, Chief Executive Officer

January 27, 2012

/s/ Michael J. Marx

Michael J. Marx, Chief Financial Officer

EX-31 2 exhibit31_1sep2011.htm 11SEP PRIN EXEC 302 CERT Converted by EDGARwiz

Exhibit 31.1

CERTIFICATION PURSUANT TO RULE 13a-14

UNDER THE SECURITIES EXCHANGE ACT OF 1934

I, Edward Suydam, certify that:

(1)

I have reviewed this quarterly report on Form 10-Q of Nano Mask, Inc. for the quarter ended September 30, 2011;

(2)

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

(3)

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

(4)

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

(5)

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions);

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information;

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: January 27, 2012

/s/ Edward Suydam

Edward Suydam

Chief Executive Officer (Principal Executive Officer)

EX-31 3 exhibit31_2sep2011.htm 11SEP PRIN FIN 302 CERT Converted by EDGARwiz

Exhibit 31.2

CERTIFICATION PURSUANT TO RULE 13a-14

UNDER THE SECURITIES EXCHANGE ACT OF 1934

I, Michael J. Marx, certify that:

(1)

I have reviewed this quarterly report on Form 10-Q of Nano Mask, Inc. for the quarter ended September 30, 2011;

(2)

(3)

(4)

(a)

(b)

(c)

(d)

(5)

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions);

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: January 27, 2012

/s/ Michael J. Marx

Michael J. Marx

Chief Financial Officer (Principal Accounting Officer)

EX-32 4 exhibit32_1sep2011.htm 11SEP PRIN EXEC 906 CERT Converted by EDGARwiz

Exhibit 32.1

Certification Pursuant to Section 1350 of Chapter 63

of Title 18 of the United States Code

I, Edward Suydam, the Chief Executive Officer of Nano Mask, Inc. (“Nano Mask”), certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

(i)

the accompanying Form 10-Q of Nano Mask for the quarter ended September 30, 2011 (the “Form 10-Q”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(ii)

the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Nano Mask.

/s/ Edward Suydam

Edward Suydam

Chief Executive Officer (Principal Executive Officer)

Nano Mask, Inc.

January 27, 2012

EX-32 5 exhibit32_2sep2011.htm 11SEP PRIN FIN 906 CERT Converted by EDGARwiz

Exhibit 32.2

Certification Pursuant to Section 1350 of Chapter 63

of Title 18 of the United States Code

I, Michael J. Marx, the Chief Financial Officer of Nano Mask, Inc. (“Nano Mask”), certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

(i)

(ii)

the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Nano Mask.

/s/ Michael J. Marx

Michael J. Marx

Chief Financial Officer

(Principal Financial and Accounting Officer)

January 27, 2012

EX-101.PRE 6 nanm-20110930_pre.xml NANM-20110930_PRE.XML EX-101.LAB 7 nanm-20110930_lab.xml NANM-20110930_LAB.XML Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS CURRENT ASSETS Cash Accounts receivable Refund receivable Prepaid expenses and other Inventory, net Total Current Assets FIXED ASSETS Equipment Accumulated depreciation Equipment, Net Total Assets LIABILITIES AND STOCKHOLDERS' DEFICIT CURRENT LIABILITIES Customer advances Accounts payable Accounts payable – related party Accrued expenses Notes payable Note payable – related party Total Current Liabilities STOCKHOLDERS' DEFICIT Common stock, 100,000,000 shares authorized, $0.001 par value, 75,997,374 outstanding (75,526,952 issued and 470,422 issuable) and 57,979,351 (57,808,929 issued and 170,422 issuable) shares issued and outstanding Additional paid-in capital Accumulated deficit Stockholders’ deficit Total Liabilities and Stockholders Deficit STOCKHOLDERS' EQUITY Common stock, par value Common stock, authorized shares Common stock, outstanding shares Common stock, issued shares Common Stock, shares issuable Income Statement [Abstract] NET SALES COSTS AND EXPENSES Cost of sales Research and development Selling, general and administrative Total operating expenses LOSS FROM OPERATIONS OTHER INCOME (EXPENSE) Gain on settlement of vendor liabilities and other Interest expense Total Non Operating Expense NET LOSS BASIC LOSS PER SHARE WEIGHTED-AVERAGE NUMBER OF COMMON SHARES OUTSTANDING Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Net loss Adjustments to reconcile net loss to net cash used in operating activities: Depreciation Common stock issued for company expenses incurred Common stock issued for services Gain on settlement of vendor liabilities Changes in operating assets and liabilities: Accounts receivable Refund receivable Inventory Prepaid expenses Customer advances Accounts payable Accrued expenses Net cash used in operating activities CASH FLOWS FROM INVESTING ACTIVITIES: Purchase of equipment Cash used in investing activities CASH FLOWS FROM FINANCING ACTIVITIES: Common stock and warrants issued for cash Proceeds from the issuance of short-term notes payable Proceeds from the issuance of related party short-term note payable Repayments of short-term notes payable Net cash provided by financing activities NET INCREASE (DECREASE) IN CASH CASH AT BEGINNING OF PERIOD CASH AT END OF PERIOD SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION Cash paid for interest Cash paid for income taxes NON-CASH INVESTING AND FINANCING ACTIVITIES Common stock issued for settlement of cash advances and accounts payable Accrued interest added to note payable balance Notes to Financial Statements Basis Of Presentation Going Concern Significant Transactions Subsequent Events Contingencies Assets, Current Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Property, Plant and Equipment, Net Assets Liabilities, Current Stockholders' Equity Attributable to Parent Liabilities and Equity Operating Expenses Interest Expense Nonoperating Income (Expense) Increase (Decrease) in Accounts Receivable Increase (Decrease) in Income Taxes Receivable Increase (Decrease) in Customer Advances Increase (Decrease) in Accounts Payable Increase (Decrease) in Accrued Liabilities Net Cash Provided by (Used in) Operating Activities Payments to Acquire Machinery and Equipment Net Cash Provided by (Used in) Investing Activities Repayments of Notes Payable Net Cash Provided by (Used in) Financing Activities EX-101.DEF 8 nanm-20110930_def.xml NANM-20110930_DEF.XML EX-101.CAL 9 nanm-20110930_cal.xml NANM-20110930_CAL.XML EX-101.SCH 10 nanm-20110930.xsd NANM-20110930.XSD 0001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 0002 - Statement - Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0003 - Statement - Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0004 - Statement - Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0005 - Statement - Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0006 - Disclosure - Basis Of Presentation link:presentationLink link:calculationLink link:definitionLink 0007 - Disclosure - Going Concern link:presentationLink link:calculationLink link:definitionLink 0008 - Disclosure - Significant Transactions link:presentationLink link:calculationLink link:definitionLink 0009 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 0010 - Disclosure - Contingencies link:presentationLink link:calculationLink link:definitionLink EX-101.INS 11 nanm-20110930.xml NANM-20110930.XML 0001088213 2011-01-01 2011-09-30 0001088213 2012-01-27 0001088213 2011-09-30 0001088213 2010-12-31 0001088213 2011-07-01 2011-09-30 0001088213 2010-07-01 2010-09-30 0001088213 2010-01-01 2010-09-30 0001088213 2009-12-31 0001088213 2010-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares Nano Mask, Inc. 0001088213 10-Q 2011-09-30 false --12-31 No No Yes Smaller Reporting Company Q3 2011 84742347

4835

2810

136908

835

650

571

2500

79889

20302

74404

14421

5673

973

324

178

5349

795

85238

21097

70130

548579

759512

80500

103300

340663

343497

497727

25000

1562599

1704036

75997

57979

20935804

20427452

-22489162

-22168370

-1477361

-1682939

85238

21097

0.001

100000000

75997374

57979351

75526952

57808929

470422 170422

-668004

-279916

-115078

-593061

695575

281804

115078

593061

673400

276609

115078

524511

3400

68550

18775

1795

27571

1888

0.00

-0.01

-320792

-287676

-115719

-603888

347212

-7760

-641

-10827

25737

8634

8751

25581

372949

874

8110

14754

67787590 73952578 50679307 53950933

146

130

331200

83850

12170

27737

2500

-2500

-650

571

696

-59983

632

-48275

-135100

-2834

341719

292216

31278

70130

-4700

-973

4700

973

30000

25000

6855

55000

2025

-136073

12620

153000 10000

NOTE 1 - BASIS OF PRESENTATION   The financial information included herein is unaudited and has been prepared consistent with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 8, Rule 8.03 of Regulation S-K. Accordingly, these financial statements do not include all information required by generally accepted accounting principles for annual financial statements. These statements should be read in conjunction with the audited financial statements and notes thereto included in the Company's annual report on Form 10-K for the year ended December 31, 2010, from which the balance sheet information as of that date is derived. These interim financial statements contain all adjustments necessary in the opinion of management for a fair statement of results for the interim periods presented.   The results of operations for the nine months ended September 30, 2011, are not necessarily indicative of the results to be expected for the full year.   Certain minor reclassifications in prior period amounts have been made to conform to the current period presentation.

NOTE 2 GOING CONCERN The Companys financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. However, in addition to a working capital deficiency at September 30, 2011, the Company has incurred negative cash flow from operations and significant losses, which have substantially increased its operating deficit at September 30, 2011. These factors raise substantial doubt about the Companys ability to continue as a going concern. The Companys ability to continue as a going concern will be dependent upon economic developments and the success of management's plans as set forth below, which cannot be assured. The accompanying financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result from the outcome of this uncertainty. Management and board members are continuing to discuss other alternative financing options, but no definitive proposals or agreements have been reached.   The foregoing notwithstanding, management does not believe the Company currently has sufficient capital to sustain its planned business activities for the next twelve months following the issuance of these financial statements. Accordingly, while management has historically been successful generating sufficient funds to sustain operations, there is no assurance that they will continue to do so. Nevertheless, the Company will seek additional capital to sustain its operations, either through additional private placements of common stock or loans, possibly unsecured, until such time as its operations are self-sustaining. These funds will be required to continue the Companys efforts to generate sales of its products and to provide sufficient working capital to meet the expected sales demand.

NOTE 3 SIGNIFICANT TRANSACTIONS   The Company issued a short-term note payable of $25,000 to an affiliate with an annual interest rate of prime, plus 2%, payable in six months from February 22, 2011. Also, during the nine months ended September 30, 2011, the Company received cash advances of $106,500 from an executive officer with no specific repayment terms.   The following table summarizes the stock issuances during the nine months ended September 30, 2011:   <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="37" style="text-align: center; border-bottom: Black 1pt solid">Summary of Stock Issuances during the Nine Months ended September 30, 2011</td></tr> <tr style="vertical-align: bottom"> <td colspan="9" style="text-align: center; border-bottom: Black 1pt solid">Settlement of Advances and Payables</td><td style="padding-bottom: 1pt"> </td> <td colspan="11" style="text-align: center; border-bottom: Black 1pt solid">Settlement of Advances -Related Party</td><td style="padding-bottom: 1pt"> </td> <td colspan="7" style="text-align: center; border-bottom: Black 1pt solid">Compensation and Expenses</td><td style="padding-bottom: 1pt"> </td> <td colspan="7" style="text-align: center; border-bottom: Black 1pt solid">Cash Proceeds from Offerings</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; border-bottom: Black 1pt solid">Common Shares</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Fair Value</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Carrying  Value of Related Payables</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Common Shares</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Fair Value</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Carrying Value of Related Advances</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Common Shares</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Fair Value</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Common Shares</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Cash</td></tr> <tr style="vertical-align: bottom"> <td style="width: 28%; text-align: center; padding-left: 0.75pt">900,000</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 4%; text-align: right">24,300</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 4%; text-align: right">257,775</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 4%; text-align: right">4,422,998</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 4%; text-align: right">129,300</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 4%; text-align: right">129,300</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 4%; text-align: right">11,495,025</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 4%; text-align: right">342,957</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 4%; text-align: right">1,200,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 4%; text-align: right">30,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> </table>    Due to the fair value of the common shares being less than the carrying value of the related payables, the Company recognized a gain on settlement of payables of $352,075 during the nine months ended September 30, 2011. An additional gain of $20,874 was generated by writing off payables due to the expiration of the statute of limitations.

NOTE 4 - SUBSEQUENT EVENTS   The following table summarizes the common shares issued subsequent to September 30, 2011 and their related amounts for cash proceeds from private placements offerings, stock-based compensation and expense reimbursements as well as settlement of loans payable:   <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="5" style="text-align: center; border-bottom: Black 1pt solid">Cash Proceeds from Offerings</td><td style="padding-bottom: 1pt"> </td> <td colspan="7" style="text-align: center; border-bottom: Black 1pt solid">Stock-Based Compensation and Expense Reimbursements</td><td style="padding-bottom: 1pt"> </td> <td colspan="7" style="text-align: center; border-bottom: Black 1pt solid">Settlement of Loans Payable</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; border-bottom: Black 1pt solid">Common Shares</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Amount</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Common Shares</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Amount</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Common Shares</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Amount</td></tr> <tr style="vertical-align: bottom"> <td style="width: 35%; text-align: center; padding-left: 5.4pt">200,000</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">7,544,973</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">330,586</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">1,000,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">60,000</td><td style="width: 1%; text-align: left"> </td></tr> </table>

NOTE 5 CONTINGENCIES   On December 29, 2010, the Company received a complaint from Applied Nanoscience, Inc., seeking collection of the as yet unpaid notes payable to Applied in the amount of $453,500, plus interest and litigation expenses. On February 1, 2011, the Company countersued for breach of contract and related claims. The Company maintains a right of offset against Applieds notes in the amount of $41,360 and is reflected on the balance sheet in the net amount of $412,140.

XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 R9.htm IDEA: XBRL DOCUMENT

Subsequent Events

9 Months Ended

Sep. 30, 2011

Notes to Financial Statements

Subsequent Events

NOTE 4 - SUBSEQUENT EVENTS

Cash Proceeds from Offerings			Stock-Based Compensation and Expense Reimbursements				Settlement of Loans Payable
Common Shares	Amount		Common Shares		Amount		Common Shares		Amount
200,000	$	5,000		7,544,973	$	330,586		1,000,000	$	60,000

EXCEL 14 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\W-V,T-V0S8U]D,CDQ7S0U,#%?83`Q8E\U,3EF M-64W-F4Y83(B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I% M>&-E;%=O#I% M>&-E;%=O#I.86UE/E-T871E;65N='-?;V9?3W!E M#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-T871E;65N='-?;V9?0V%S:%]&;&]W#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D)A#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/D=O:6YG7T-O;F-E#I7;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I3='EL97-H M965T($A2968],T0B5V]R:W-H965T3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W-V,T-V0S8U]D,CDQ7S0U,#%? M83`Q8E\U,3EF-64W-F4Y83(-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO-S=C-#=D,V-?9#(Y,5\T-3`Q7V$P,6)?-3$Y9C5E-S9E.6$R+U=O'0O:'1M;#L@ M8VAA2!);F9O'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!#96YT3PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^,#`P,3`X.#(Q,SQS<&%N/CPO'0^,3`M43QS<&%N/CPO M'0^ M+2TQ,BTS,3QS<&%N/CPO'0^3F\\2=S(%)E<&]R=&EN9R!3=&%T=7,@0W5R M'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^,C`Q,3QS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'!E;G-E6%B;&4\+W1D/@T*("`@("`@("`\=&0@ M8VQA6%B;&4@XH"3 M(')E;&%T960@<&%R='D\+W1D/@T*("`@("`@("`\=&0@8VQA7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\W-V,T-V0S8U]D,CDQ7S0U,#%?83`Q8E\U M,3EF-64W-F4Y83(-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-S=C M-#=D,V-?9#(Y,5\T-3`Q7V$P,6)?-3$Y9C5E-S9E.6$R+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M/B@W+#3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W-V,T-V0S8U]D M,CDQ7S0U,#%?83`Q8E\U,3EF-64W-F4Y83(-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO-S=C-#=D,V-?9#(Y,5\T-3`Q7V$P,6)?-3$Y9C5E-S9E M.6$R+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!E>'!E;G-E3PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'!E;G-E'!E;G-E2!S:&]R="UT97)M(&YO M=&4@<&%Y86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S2!F:6YA;F-I;F<@86-T:79I=&EE'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6%B M;&4\+W1D/@T*("`@("`@("`\=&0@8VQA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W M-V,T-V0S8U]D,CDQ7S0U,#%?83`Q8E\U,3EF-64W-F4Y83(-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-S=C-#=D,V-?9#(Y,5\T-3`Q7V$P,6)? M-3$Y9C5E-S9E.6$R+U=O'0O:'1M;#L@8VAA'0^/'`@ M6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VUA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W-V,T-V0S8U]D,CDQ M7S0U,#%?83`Q8E\U,3EF-64W-F4Y83(-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO-S=C-#=D,V-?9#(Y,5\T-3`Q7V$P,6)?-3$Y9C5E-S9E.6$R M+U=O'0O M:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE28C,30V.W,@9FEN86YC:6%L('-T871E;65N M=',@:&%V92!B965N('!R97!A2!W M:6QL(&-O;G1I;G5E(&%S(&$@9V]I;F<@8V]N8V5R;BP@=VAI8V@@8V]N=&5M M<&QA=&5S('1H92!R96%L:7IA=&EO;B!O9B!A2!A="!397!T96UB97(@,S`L(#(P,3$L('1H92!# M;VUP86YY(&AA6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M28C,30V M.W,@86)I;&ET>2!T;R!C;VYT:6YU92!A2!A;F0@8VQA2!C=7)R96YT;'D@ M:&%S('-U9F9I8VEE;G0@8V%P:71A;"!T;R!S=7-T86EN(&ET2!U;G-E8W5R960L#0IU M;G1I;"!S=6-H('1I;64@87,@:71S(&]P97)A=&EO;G,@87)E('-E;&8M28C,30V.W,@969F;W)T7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$6QE/3-$)VUA6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M"!M;VYT:',@9G)O;2!&96)R=6%R>2`R,BP@,C`Q,2X@06QS M;RP@9'5R:6YG('1H92!N:6YE(&UO;G1H2!R96-E:79E9"!C87-H(&%D=F%N8V5S(&]F M("0Q,#8L-3`P(&9R;VT@86X@97AE8W5T:79E(&]F9FEC97(@=VET:"!N;R!S M<&5C:69I8R!R97!A>6UE;G0@=&5R;7,N/"]P/@T*#0H\<"!S='EL93TS1"=F M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1E6QE/3-$ M)W9E6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE M/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E M6QE/3-$)W=I9'1H.B`R)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q M)3L@=&5X="UA;&EG;CH@;&5F="<^)#PO=&0^/'1D('-T>6QE/3-$)W=I9'1H M.B`T)3L@=&5X="UA;&EG;CH@'0M86QI9VXZ(&QE9G0G/B8C,38P.SPO=&0^ M/'1D('-T>6QE/3-$)W=I9'1H.B`R)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M'0M86QI9VXZ(')I9VAT M)SXT+#0R,BPY.3@\+W1D/CQT9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M M86QI9VXZ(&QE9G0G/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W=I9'1H.B`R M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$ M)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^)B,Q-C`[/"]T9#X\=&0@ M'0M86QI9VXZ(&QE9G0G/B0\+W1D/CQT9"!S M='EL93TS1"=W:61T:#H@-"4[('1E>'0M86QI9VXZ(')I9VAT)SXQ,CDL,S`P M/"]T9#X\=&0@6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@ M;&5F="<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W=I M9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^)B,Q-C`[/"]T9#X\=&0@'0M86QI9VXZ(&QE9G0G/B0\+W1D/CQT9"!S='EL M93TS1"=W:61T:#H@-"4[('1E>'0M86QI9VXZ(')I9VAT)SXS-#(L.34W/"]T M9#X\=&0@6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F M="<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W=I M9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^)#PO=&0^/'1D('-T>6QE/3-$ M)W=I9'1H.B`T)3L@=&5X="UA;&EG;CH@6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^)B,Q-C`[ M/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B8C,38P M.SPO=&0^/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0G/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!L969T)SXF(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!L969T)SXF(S$V,#L\+W1D/CQT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B8C,38P.SPO=&0^ M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0G/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T M)SXF(S$V,#L\+W1D/CQT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!L969T)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B8C,38P.SPO=&0^/'1D/B8C M,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G M/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SXF(S$V M,#L\+W1D/CPO='(^#0H\+W1A8FQE/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6%B;&5S(&1U92!T;R!T:&4@97AP:7)A=&EO;B!O9@T*=&AE M('-T871U=&4@;V8@;&EM:71A=&EO;G,N/"]P/@T*#0H-"@T*/'`@'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W9E M6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG M;CH@;&5F="<^)#PO=&0^/'1D('-T>6QE/3-$)W=I9'1H.B`Y)3L@=&5X="UA M;&EG;CH@6QE/3-$)W=I9'1H M.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^)B,Q-C`[/"]T9#X\=&0@6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F M="<^)#PO=&0^/'1D('-T>6QE/3-$)W=I9'1H.B`Y)3L@=&5X="UA;&EG;CH@ M'0M86QI9VXZ(&QE9G0G/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W=I9'1H M.B`R)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SXQ+#`P,"PP,#`\+W1D/CQT M9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/B8C,38P M.SPO=&0^/'1D('-T>6QE/3-$)W=I9'1H.B`R)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA6QE/3-$)VUA6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE65T('5N<&%I9"!N;W1E'1087)T7S XML 15 R8.htm IDEA: XBRL DOCUMENT

Significant Transactions

9 Months Ended

Sep. 30, 2011

Notes to Financial Statements

Significant Transactions

NOTE 3 –SIGNIFICANT TRANSACTIONS

The following table summarizes the stock issuances during the nine months ended September 30, 2011:

Summary of Stock Issuances during the Nine Months ended September 30, 2011
Settlement of Advances and Payables					Settlement of Advances -Related Party						Compensation and Expenses				Cash Proceeds from Offerings
Common Shares	Fair Value		Carrying Value of Related Payables		Common Shares		Fair Value		Carrying Value of Related Advances		Common Shares		Fair Value		Common Shares		Cash
900,000	$	24,300	$	257,775		4,422,998	$	129,300	$	129,300		11,495,025	$	342,957		1,200,000	$	30,000

- Definition

The entire disclosure for related party transactions, including the nature of the relationship(s), a description of the transactions, the amount of the transactions, the effects of any change in the method of establishing the terms of the transaction from the previous period, stated interest rate, expiration date, terms and manner of settlement per the agreement with the related party, and amounts due to or from related parties. If the entity and one or more other entities are under common ownership or management control and this control affects the operating results or financial position, disclosure includes the nature of the control relationship even if there are no transactions between the entities. Disclosure may also include the aggregate amount of current and deferred tax expense for each statement of earnings presented where the entity is a member of a group that files a consolidated tax return, the amount of any tax related balances due to or from affiliates as of the date of each statement of financial position presented, the principal provisions of the method by which the consolidated amount of current and deferred tax expense is allocated to the members of the group and the nature and effect of any changes in that method. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 3A

-Section 04

-Paragraph b

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 57

-Paragraph 1-4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39678-107864

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 4

-Section 08

-Paragraph k

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864

+ Details

XML 16 R2.htm IDEA: XBRL DOCUMENT

Balance Sheets (Unaudited) (USD $)	Sep. 30, 2011	Dec. 31, 2010
CURRENT ASSETS
Cash	$ 4,835	$ 2,810
Accounts receivable	650	0
Refund receivable	0	2,500
Prepaid expenses and other	0	571
Inventory, net	74,404	14,421
Total Current Assets	79,889	20,302
FIXED ASSETS
Equipment	5,673	973
Accumulated depreciation	(324)	(178)
Equipment, Net	5,349	795
Total Assets	85,238	21,097
CURRENT LIABILITIES
Customer advances	70,130	0
Accounts payable	548,579	759,512
Accounts payable – related party	80,500	103,300
Accrued expenses	340,663	343,497
Notes payable	497,727	497,727
Note payable – related party	25,000	0
Total Current Liabilities	1,562,599	1,704,036
STOCKHOLDERS' DEFICIT
Common stock, 100,000,000 shares authorized, $0.001 par value, 75,997,374 outstanding (75,526,952 issued and 470,422 issuable) and 57,979,351 (57,808,929 issued and 170,422 issuable) shares issued and outstanding	75,997	57,979
Additional paid-in capital	20,935,804	20,427,452
Accumulated deficit	(22,489,162)	(22,168,370)
Stockholders’ deficit	(1,477,361)	(1,682,939)
Total Liabilities and Stockholders Deficit	$ 85,238	$ 21,097

XML 17 R6.htm IDEA: XBRL DOCUMENT

Basis Of Presentation

9 Months Ended

Sep. 30, 2011

Notes to Financial Statements

Basis Of Presentation

NOTE 1 - BASIS OF PRESENTATION

The results of operations for the nine months ended September 30, 2011, are not necessarily indicative of the results to be expected for the full year.

Certain minor reclassifications in prior period amounts have been made to conform to the current period presentation.

XML 18 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'

'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'

'+ "\n"+' '+ "\n"+'

'+ "\n"+'

'+raw+'

'+ "\n"+'

'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } } XML 19 R7.htm IDEA: XBRL DOCUMENT

Going Concern

9 Months Ended

Sep. 30, 2011

Notes to Financial Statements

Going Concern

NOTE 2 – GOING CONCERN

- Definition

Disclosure of accounting policy for reporting when there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date). Disclose: (a) pertinent conditions and events giving rise to the assessment of substantial doubt about the entity's ability to continue as a going concern for a reasonable period of time, (b) the possible effects of such conditions and events, (c) management's evaluation of the significance of those conditions and events and any mitigating factors, (d) possible discontinuance of operations, (e) management's plans (including relevant prospective financial information), and (f) information about the recoverability or classification of recorded asset amounts or the amounts or classification of liabilities. If management's plans alleviate the substantial doubt about the entity's ability to continue as a going concern, disclosure of the principal conditions and events that initially raised the substantial doubt about the entity's ability to continue as a going concern would be expected to be considered. Disclose whether operations for the current or prior years generated sufficient cash to cover current obligations, whether waivers were obtained from creditors relating to the company's default under the provisions of debt agreements and possible effects of such conditions and events, such as: whether there is a possible need to obtain additional financing (debt or equity) or to liquidate certain holdings to offset future cash flow deficiencies. Disclose appropriate parent company information when parent is dependent upon remittances from subsidiaries to satisfy its obligations.

+ References+ Details

XML 20 R3.htm IDEA: XBRL DOCUMENT

Balance Sheets (Parenthetical) (USD $)	Sep. 30, 2011	Dec. 31, 2010
STOCKHOLDERS' EQUITY
Common stock, par value	$ 0.001	$ 0.001
Common stock, authorized shares	100,000,000	100,000,000
Common stock, outstanding shares	75,997,374	57,979,351
Common stock, issued shares	75,526,952	57,808,929
Common Stock, shares issuable	470,422	170,422

- Definition

Total number of shares of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares represent the ownership interest of the common shareholders. Shares outstanding equals shares issued minus shares held in treasury and other adjustments, if any.

+ References+ Details

XML 21 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information	9 Months Ended
Document and Entity Information	Sep. 30, 2011	Jan. 27, 2012
Document And Entity Information
Entity Registrant Name	Nano Mask, Inc.
Entity Central Index Key	0001088213
Document Type	10-Q
Document Period End Date	Sep. 30, 2011
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		84,742,347
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2011

XML 22 R4.htm IDEA: XBRL DOCUMENT

Statements of Operations (Unaudited) (USD $)	3 Months Ended		9 Months Ended
Statements of Operations (Unaudited) (USD $)	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
Income Statement [Abstract]
NET SALES	$ 1,888	$ 0	$ 27,571	$ 0
COSTS AND EXPENSES
Cost of sales	1,795	0	18,775	0
Research and development	3,400	0	3,400	68,550
Selling, general and administrative	276,609	115,078	673,400	524,511
Total operating expenses	281,804	115,078	695,575	593,061
LOSS FROM OPERATIONS	(279,916)	(115,078)	(668,004)	(593,061)
OTHER INCOME (EXPENSE)
Gain on settlement of vendor liabilities and other	874	8,110	372,949	14,754
Interest expense	(8,634)	(8,751)	(25,737)	(25,581)
Total Non Operating Expense	(7,760)	(641)	347,212	(10,827)
NET LOSS	$ (287,676)	$ (115,719)	$ (320,792)	$ (603,888)
BASIC LOSS PER SHARE	$ 0.00	$ (0.01)	$ 0.00	$ (0.01)
WEIGHTED-AVERAGE NUMBER OF COMMON SHARES OUTSTANDING	73,952,578	50,679,307	67,787,590	53,950,933

ZIP 23 0001179350-12-000019-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001179350-12-000019-xbrl.zip M4$L#!!0````(`"XP/D"7X,P^WQ<``/JX```1`!P`;F%N;2TR,#$Q,#DS,"YX M;6Q55`D``XAX)D^(>"9/=7@+``$$)0X```0Y`0``[%U;=]LXDG[?<_8_8#W3 MO2^2S8LH2DXGIT1W9;[NZ91XJ$)$PH4DV0MM6_?JO`BTB)E'B3$V>2 M!\<6"=17A;H!*$`__>-Y99-'ZG'F.F_/Y'/IC%#'="WF+-Z>_3;MCJ97X_$9 M^<>[__XO`O]^^I]NE_SZS['C4\\P??9(2;<+SWYZGGDVN\2?!'IT^.4S9V_/ MEKZ_OKRX>'IZ.G]2SUUO<:%(DGSQST^_3,TE71E=YG#?<$QZ%K>RF?,YKYT\ M'`XOQ-/XU;TWD7A,0[W`QS.#;WM&@`?>WT,"3RT_:9!^6;L('V9>9;FO]L-7 M6?RJ17?>X]0\7[B/%_``WI?EKB1W53E^W:/S0LC]"W@:O\BXVU-D_1!_X1MQ M@X!W%X:Q3AK,#3X3+TA)JT)ZG0J8$M*.)IU$2%(7Q@(1L[RMR7GZF'ZI'(.G2L0>-W.-6;@Q!'H M-2I@)@*U'*8#AX42^FUZO2>6%35XX-%WT33E$MZ).XL?94E@;P7]3Y>&1WDA MB48*>0*%&>_EC5#.>[I@W/=`NR;&BI)(>>YQ"G=H`C8Q')=\ M,OCG#AD[YOE/%T4][E.\`JOP#'OL6/3Y9[HI33)M>86]I,_P(RS M-!4PO5_#_M/-\[J]$\9W$SKYTOVGTY["WM+D1O#4PC<^V,:B-)FY87,:4LAT MD.[Y*O`\_)AQT[#_10VO*B_=V)4?ZFU?`?Z@MOVSXSXY4U!PUZ'6F/,`7&]I MW7/3"E#0VS[9WUT[<"".;SXPFWJ\)KF=7G+4.Y3#/5V[GL^BHFAQI6C1C^GD!C),85V@S=G344 M@KY6/(C"%+&HR4#8_.W9>/+A[-V@I_<4M:=GAOH`L1A:M$!X>67P91Z`F-DM M`(SW*>H@A]Y`U7ZZ2/=4MO=X8G^H=V4@2[5Z3S+;0[W+:G\H#>JB/RZ;HZ(9 MF:8+]L_OJ4G9HS&SZ83ZD9'6'9"^EI+8(0)-P909OYI0[CRZ-IAU\[RF#JB&OIP,!BF%/:0M%L91*E7+8L#?5C)*X"[D/,\D;6(]8A-(Y+DJRFL^#\WAN`J)C)E000)WQWQ@9# M=D,A:+V!I@_WT\EL[_4QE%)K;:C)2D,,]U1XE#L#'$=CU1A(F5RI#*FVX)5R MIY*JMH#/"ZCU"S-FS&8MR$SM2?V^F@&53Z`1DC+B47O@M?4:2":N3UNR*P"@ M*RD,.5W7I%Y&`@VI[RB0;7".6R=60YG@!$3*!W6$8LM@*SKF!D#;,R]9ZRO: M,.6ICZMS>Q8EZU)/4OM5B*<6RGXW[*#VE!F"0]J6=[NM0[;6"_;[K42\E#!"%,E2'5:BG/`M,:MJ3Q,XDYAB9-F#5 MF/A4A97R2Q"2;CW<>:*6<%%WU!,[%*4%=E>P#2*=2Y*U7O'4!U:,>M M(JS2TA+I@*KE*UAU6&+WNYE6Z9JF](?IT%Q`I0&8"N(92(.ADI\PY8'!\POY M[Y3?7BG`TH-<50&Q'"91'TAY"ZL$)!;<[1H+E4")P@V:7W97Q0]LGA\,Q?W^ M0$HGE#ETZD/9*Y(^G"+I0TC@3@$EKX[X<((B:U)Z;;I5*'NEM@>A:$-52B=J M5:!$&YJM:`HX%4W7Y*IK(Q15]:-0/9JBJ*0:A9I1A&)* M;1L>?Z0.O&CC?HJU8HZH]\,#B5&S5I1%5WOI%*(>\JIX9E+>/^:/E+;%?M:+:IM5FD/DFL#6R45?4EL5=7Q M)8%5TKO^0-/J@KMRN7\[OX?WG*`5[9('>CJ`9OJO0[R2^LB93>)FM!NH1V/" ME8:_+.&I86.YDWBVNP]?<[`5/5-AMD.A'H!J`SX8#-JDWV#06R%>=^"/$(]7 M7^/5G_<&9V8M!3BT`K6%DTNO":C#2O$E0!W5E")074`EGQ#5815J$Q4H6LOS M=%61]&%J52=#H0[YBG/S@=[7^VV1KS,?U^5AB^2KS<'[DIKQIH?)NXZ;G:.W MFJ'J2KHFII!84U35U$/7^]*I0556FGY/?@%,U31)E@;9`HR2J,2]092W.=E1 M-%U-0=FA4`]`):T9]-5>F_2K*LA`U^26Z5=2!D73!N4!?#28P]'?4'[KW#RC MQ@2,+W$"A9>N:?C_V#E^3+)VZKQS9+(,X1;Q5IYV MG`CP_B'C=FH2M(-@]ZFVA;3!,F,[,*.#R-=T3CV/YA](;D/$F;7I>C!.QTSE M39YA__3,Q,=I63O5%%UM.!RHATTR(=@8766)JDI-:'C)@,&7=YZ+EQA9[S>_ M@=<>.TEIP@BO/A9UK*U(L3=0TEMJY:FWB[OZ,I"JR9DS+[6!Y_J=G6--K8A: M&617:XZ3;0MJ5>FJ/3FS6-P:UO1ANE;2B"&>"B@30R*BK:"L+$Y929>:M`!R M]T1K&[+<.;5[G&@[,%O-&(Y!+/`2Z([Y*9RK7L)%Y1!O%W9EWYJY]*$^:M!F M7/KB#^[(_#-@'OUDF$OF4&]3>/-!34%GY5R.;GMHJ\HW>Z=&/;">:U)J<42P MG1"G2J%;63;('F(X2K,5D`W<02.`J>.GF[;V`G:.Y1XBUQ1:2V*K`BM]>+<- M:15`2I-I`J=.X5MU1/X^GK MEJTUW755LHW2XT-DD^7*DS"Y[X@[46"NB^6PLLI;E M48IF:T`K;UPI?:4NV-TC>.%A1+$3X_LV#;>^T0CC&1F>5&A_'4#65.'H6X!S M8LXJ#X[4-F/Q.+\/.,PS.+^FW/38.KH@#HLQ(83?P2!#GV*;Z`%8>&]7F%2\ M^]'VWZP)]SDML/Y.[^9GHS>1@]C&\G@OXL;G`:)*=G]F%)R3Q,!PR;,&?N>JMP M'Y$YIAU`TD"68+,,_N:@:49@,4CQB>'`YP8G,TH=`6:-J_Q>>%X9=,#'V>X3 M\Y=D$9XQLC?$,$VZ%HU#U<*B@K4'9-C:!L!`&6B"@V"K`D1(5/3I`V@FG(R) M#SCQ70$"-'I%\!)Z\>K(\YD)=C3HD/L`_S^75.+.R3U=X#4?V..T^_,Y04WW ML+C`WG2P:YZ6",<+"D1F2BR7.*X?RX4`3QET'A4S<$L@F6VJ,6XX3@#4\NB> MDP>!*86$+]W`MD#X0-2P``5*_=^!(Z0A1"1`H)CB`# M#GUB\^A*\__E,4)/W'9.@$PL[)\%`_CRAAH>H0XVASR)8B&'P*'*'8(.JT/F M8/;D:1\I>&3RR\51^4SP+->*16+(Y]54DQAJ[& M`!9PC`SKWP'WQ><"C0/0.#>\3FH2!9-+>;;`?=/(*#X2QZ-^125'`>= MJ%)'0$&OWB%XC0@:3BQX9J/H+6:*LX;A.&^I@1*"7M/G-36%WD;DY@$,)2K8 MJQ;K%?6$7JZ8`WQYU(PN*C,CX<(C<`SP*-0F8JQ$#`97"X)*?.W*`/<#<@(M M1XO!7U%$9G296-1VG0K"^4++YVTOXB9-MUE>]>B_?W$/>$MP39MKQDW;Q>]J M>>V9@D(BDIKTAGR\'4\^DJO;R=7-_8E3A7,9U$9*&6[DM",TO?X;GN\E$ZTB M$`E@Q7&J%0`@*!BA]>5,3P;".[9(`LW*@LTJ0?H0K6ZA`\L3>[@8*&)%W=C`F(.G`X\)9S"+=.R?_YS[11^IU MT&R,Z`(T-`:#/+G>9P$NNF?-$A=Z4<>$8.QG'14)G52:5TQL(!"B.5E1R%B$ MOLK$KT>8V^Y3&,E2;A$9XFSA"&,&([1%(6\L%2%I'LS$-U$QD12P:&H$H19] M;+S3'$'U,SC#*!IAC0/@W#!]U^/$,QC/=`Z)2C"##F9NX*?Y2NM#*.I-Y$6* M!O4DOK:,NI:#)^`(Q82(8=$UAB$0?;`&-:#PCKMB)GR>'#0.1PDEP@,38U$V MY$.2`WJ+8PD9%A49`.2:,VC]E&@W9$$0R6:(!ET6!'G$@%Q@;B?X0("E\D?0 MM%1N`H9BAQH0N7.(#B[6Q$:B0.C9<)&8D\!@&IXG:,P"AF6MX%ED)W>4DOD8, M1C%BSP*?'Z#X,>V$)`TR*"S$./Z"<^$L:%@S)B>H(>"4W!`>\4NUMB;!>IDQP0@C3QGZC] MF*2"<]<&>XFB1^C'H\VT*-$KF%WM3,/`W&#&EN(/08/J8=63*?RG&./(CB$Y MC*9;PH!2S,T#QPK#28J]K=ONA!,?G%Z`B@F;%E"%+<"CW;B'N@O]N.]Z-$((XDWB#HB2QNXUGNQD771!LZ!Q=:3)+CT8*".'1<&1#Z)OG6C"=CWRT MBW_CGD5Z,'>C.KRUPHDCDDTF#&&G%@7="6T?;:^J'9YM;1E-&YL59F_UL^A# M.?#^7MQV;_4!E)0;X=+'MY,^JZGT>3K^.!E_&%^-)@_DX7XTF8ZN<,EM^NVL MN<7>@H6W_!FXIN/Y78B$*[$D0];1*C"8Q]\5K2-)DDAM(=,%>X"X[=,H_8$< M!3\-EV=8O+(O#`S:@M]84?`(=L")\D,GZ1:<#V?/B=?&2/^!SKP`UT44)*,'&Q4',GXVXG@M9DZ5^1P/>!`+@@SZ#PXK6 M!<#NH4O!(7AG#@:.R0LN086;Q02EQ;^!`)^$3#$T,/N"E]A?T00J=.YQ%.6[ MHQ&N"!2NPXC1N/R"(@IY,JEMKS&<.0OW!D&:$P6NC`!70#BF>O[[FK[-OI7T0(7K1&-\_9,U1,LZ$+CIB:NZ'EO MH`O/HEXW[.F2O(=@_)G(`)"[-K-$UU,Q>AM4[K!,:9PWBATT M%C.FW>'IU!.+5FTJV@^XA2%NV/[:D5[%2QA;NN&718A-N]@,7\2W-.?ENXJ< M5$7V%"/VWE\]!]\5XS]>K!CM3AC5HBQ:&4`2G8EAPO5HJG2ZZC',1=2SN?B%;"MZ1U= MUUXGW^6)%PN@U^DI2FED9_D>J_*OFNPV5E^5.;ZAU).65FGV# ML5=[8.N:_CKY;F7L.TJYZ/QUBJ#)T)^([392KB-RK2K%NN.6+[B*#\,?6?HRS&T&[DOQ";C]J/7M`.\)7$=%AB):G=<=WN,ESA%<7=4 MZ2/6M\B,XAHHUAYAJ9*3%'LE18"9MEZT1!KM_?.]S7EWX8@OKC3(0M1'.5C_ MF-H9BQN*'7M54SJ2KM79ASXG(R==U!12PP('J3/0>^3)X'$=%U:>;D&=0/WJG0H5.7LW-P8S3O\, M\+MO'L7U':^\=*='NF3ZV_OIS:^_W4P>R,WO\/,;JM4Y4J"1-:&X58+1-V@DK1;HS451N[NP$"Q0TNCS= MHVPUPWKZJ"J:DR>*)Z7XCMV+<#?\J]O)%T4O77%;+"DJ M1R#W&07\ZEG*&(5P?5%UR"_"0*(]Z1,L+_PG;8J-A.O[VE%^%^EWD>Z)]`2; MMZI6:O-6.^]%IVAKKY.$308>!5R M8&W0?YU\MS'T,FK^Z]7^!D/??Z'MG-Q%H?K3_<(Y^_ZWJ*Y6+#S3.7*L*W$V M:D$=D]%OZ+".EC[K?G4[>1A//MY,KL8WW\BT_]9)KC`ARC"^OB3W3(LAYMHV MGH8-IVJC]=IFT$3S%)\[$ M0<+PR+-M4S,^MRL.]G*RH3X)'+Q=/[K&)3[=X[LQBOB2DW!A06#"!;>>IN*Q MF^A@4')J*#R6[[-%.&6+U@OX.0%Y),>#Y+PC/N)B&^J)M0]+VD?DNY'1X2=)WD>.KN'331P58_VXW2D?]_)@:$=QH1 M4Y"05CX`2Q<;_8JDHIQ,*Q`)Y`(`4$L#!!0````(`"XP/D#A\%4^*`@``%)A M```5`!P`;F%N;2TR,#$Q,#DS,%]C86PN>&UL550)``.(>"9/B'@F3W5X"P`! M!"4.```$.0$``.UCO=5@`DI!$F=X>MFV&[/SP:#%H!%XA$**8$#EN$MC[]\>LO@?PY^*W=#O[\ M-B`"&`H%GD+0;LOO#F),?NRK7[>(0R#O0?C^`\>'K;$0D_U.Y_[^?N=^=X>R MN\Z;;K?7^?;E?!B.(4%M3-2]0FCE6JJ5*KW>WMY>)_LV%UV1?+AE<7Z/W4X. M9]&R_!8;Y)>0<+S/,WCG-$0B0/D43>M=?K[NUVU3U?V>B*V41RSW$RB:5'.L^%^1G%RJ?#,8#@ M=;@JA38+01P*)$#QPB]'EQ,YPA0?M4XS:VT`VA'B MX].8WC="MJ+T8K1R+)N_8L#EC:QZOT'EA4"=41E.CZCL-*P6397L2Y&&[P@> MR8Y*Q%>&"%<1VZ9#F=5>"EQZR^%G*ADXF:HN4HM*(_]"<"0#0A(A M%/0WA[LZN"^`OI'H%@%#?IZ+!X_RP>\W!*41%A"]SE-F#C*F80%8K'(V9442 MY[BRQ#Q"_#;+SBEOWR$TZ2AR.Q`+GE_)Z&YW>_,D_6I^^7N?0W MB-$MQ-EMOU_T+[Z49#KNT*J8JP'Y^%49VQ+=?18&E$7`9)'8[>:M(!86:%ZM M=>82'9XFCUVJ+3E+"[L9#`G'JW'X8TE8'H M&D+`4W0;PP6(FJYA5+%CXXTS-FP,]HZE@9S<)/`5/<`2;@T]&ED[7G:=\6(T MT3M"9-DU03@Z>9@`X2"3V*6LIIE-8+72M"/KK3.R&ICO'74#HBHORF9RW&N' MT+*('1GO'(Z<58.\\_H5HW)6)V97LA[*BKZ?*9ZH(DG/@EG%1UO.&.6\J35S M)<=5C`T_Q0A@XP/ONJ',_FFBW`K1,4P8A#ASC/P<0^9J$O43R@3^)[NNM5)? M&KU0\X[+J*;=X:7]6M%QVHY[3A:&C;,EYX.XB+'`S_-3LY,"OE'(\3GOG6-T MBV,L,-34A56"+F?=*1>R'F?]:*H6,&K`:Z4=#PB]]PL3=+.MWO6I?`I[A69J MDF0W6R\+.Q[F=LR8+?6=F&O($N(58O7#WT[5\23^6:09O>`CA2R%R#IL&^0= M3^*MR3+;ZQU#%U2`7>BKE'0\F[=CQ6"CUWR4QGJ,.,5*TT22C)0?Z$XU2V3KXHYKE7U_B[4 MJAKKO.L^_2C"RF(47R$<#<@1FF#QM-FDG$9UTH[+5#M2:FSUCIMK$`@3B$X0 M(YC<\<+JS0B'6!>I;10=UZAVC-E[P#OREC)0GT364;I>S9^YNM&N91K7+5O= M37JM331(&4T\Z)0M/)?__S?[8JJW%RXVR>S6;)(IJ+_>Y&Z>FEV'"\1O2XB? M]`(Z"IXT/=G@,P=$[N8/:'7+UA5R3@LW+BY'US`%8JC:"C*.0Y;6S\6*K<(L M[[+*-7"0<,8R+AU+J#'-5M;G=FFK`:..XV!K18Z5V=Z1-818MGEW!D2:&*MG M:U&"">9"&3P%,VNVRH[K."OZFCG".QX7-CYN?CK7[QZHE'39`U&L]FEE,4V_ M@V-%RI=XO>KO0J^J-L[+DM+2)/UH\NY!^P4EM&B4.9X9Y!U:<2:GEURQ`?R2 MG#PH<"GF8Y5=+D?'<*L;,A9ZC@=1+3_+_<[:#=[%YNQT(/":$FA%RG$X:$2. MQD0/0P*(V@Q9DG$]2*H05P;D"C$?\TRM0?4]SZ?E"O.AOL6\_YUQWJ\4@TS3 MDWF_.LD@,5TQ.L72&9]G-QRB`5GTM;XZ[)PM/^D'D74#_\>#9L.G(3.%L54Y M^'S+F,L;/S6D%$7O19/:` M=X0-.$_56OCE*%OW[Y/H;\08D@GGE+(AL"D.927-CF*$$UWD:]B&XVU*Z]'[ M+']YQ[KSR>+&MCNMQ^XZLT?'4Q:9KQG(L',,CW\'9/7@J79.::/J>!_4FL.V M@7>\&ZVKX!L>S[73MB/XP[80O%WG>ZOP/YZRU$^>:G3L^/RX/7RN^&,+6)P? M7#Z&$3`&U0>8K>FU:\R.][UMX;V)![>@0Y3/_EB3OZIHO<2P)4SK7+,%K):. MH#0NM!9ZEIQZNFYD[9CMH+1T4*4)JRNJEL1ZNOC4Q#W><:LQ7144?)U5ZLH& M7+XF`LVR1P5?:3_\F6(&7U`XQ@38S.)-`K;*?JYK&[@LG.ANY"'_)OD:ZT\Q MD0ESC9Y$?AM9QLS>;/J2U&GE[<&_S+#42P= MWK,8?QH]/Y_7/&,0&OWBU6X1T[N6%WM%WJL7TV(>QI2G#+)C+5(KN!P%1;W- MG6:I?`GS`M^',KY,/%C(;_"43`L``00E#@``!#D!``"]F%%OVC`0Q]\G[3MXV?/YO#/O=H2\\XY\/_!N M?UZ,PP0RZC)N89<'W*HW.NF;X?\5C(K*#%,RC" M)1)B+#7E&68-`K_7]4W.M\_QZOLIMHEBV33%'?%>BOF5IF9/QPF`5DU(V M0*ZHQ--/0+.0ICM1U3KWA#C65(.IB[J,+Z=X,9IZ-&[:=E<+:&=4)=]3,=^) M;,VTM[(JAN&O)"A,]*SNWV+9$]0/@7?>,X%-(QMIZK3[*AJ[XRS&1N7ZMZ1< MF9O[/5!FB? MVR9S(Y%1MB/TNOL`Q$4F-X-L`G)'W*JU?5::IKL1%H;VN;C0I[NBE9Z#]B3$ M-$_UBYNRM%>9\3#CS-Q&+_!KA1L6&G@$44EN`O[OW(>'31`?AW+BDM*Q_!%_ M")`'.ZGX6\.N'^TLYQ'"V7$!/S_*R8.>O+OA-(^8ANC]H1CK!ST+W&T`KMC; MA&X8_RSPAQ7@)Q\1,7ER'FBOM\^&EOIX*[4QDL)YL`[9/#I:YH_F0F,J3(7* M)12]@2YR&9.JKS7*VI'2XGU:Q2ODQ.K;*WG#7&D)/Z\2+CE)U=H>[*9QTU+V MUBBMA92>UO#J)]"2+?!7V5;TAFO@5?Z_@T?^`5!+`P04````"``N,#Y`1JW4 M[NL5```_(P$`%0`<`&YA;FTM,C`Q,3`Y,S!?;&%B+GAM;%54"0`#B'@F3XAX M)D]U>`L``00E#@``!#D!``#57?MSVS:V_GUG[O^`=7>VR8P4/])LZFRS'462 M$TT=22O)27?NW.G0(F1S2Y$J23EV__H+@`^!Q(.@+(/'.[.M2YT#?@?X")R# MQ\%//]^O?72'H]@+@_='IZ].CA`.EJ'K!3?OCZ[FW=Z\/QH=H3AQ`M?QPP"_ M/PK"HY__]3]_0>1_/_VUVT7__G44)#AREHEWAU&W2W[[R?>"W]_1?UP[,4;D M'4'\[C[VWA_=)LGFW?'QMV_?7GU[_2J,;H[/3DY.CW_]?#E?WN*UT_4"^JXE M/LJU:"DRO=/S\_-C]FLN*DC>7T=^_H[7QSF1YY#$WKN8P;L,ET[" MJJKV-4@I0?^KFXMUZ:/NZ5GW]>FK^]@]RFN6U6`4^GB&5XB9^2YYV)#JC[WU MQJ>@V+/;"*_D8/PH.J;ZQP&^<1+LTA>=TQ>=_H.^Z+OL\:5SC?TC1"6O9B.E M7>>ELC*E8]M@ISCR0G<8[(>ZJMT2_'GB1,DC#.#UK9NP"!/'WPL\KVD=]ACO M5^,[/?LU33IEO%]-$G^*@'']PD.7.SFT&E9F@Z.O8KUNUG91>GA MLE2N3SO+,"K72.`$:V+QZ>G)^>L39N^X-_[\VR!<;MNJ:UG2%=^T23.A$X MZ%[-C_Z5JR*BBU)EQ&G_=+Q[V3ZTR@QBQL1X^>HFO#MVL7=,F4;_8)3KGIQF MP^QWY-%O*8H9OO$H\B`9.VM3(%-S(A!&31D2\#7;D_=B" M%"LQJ_RS+2[(0.44X'\#T?(20,K!@LJTV405 M6NT<4F?E*_;]7X+P6S#'3AP&V!W%\19'$G-KY.VZDS6PRVZE0A@$B4P05IDT MBO/`U$%4L_L[546Y+DJ5?VZ/5%]"?QLD3O1PX?DXBI5F"W)V2:2`629/10@0 M:>3(=&0I-!!3:9$A66X`1+CWP!8>QI-B$T4[7!K'V,H51KHM#$\! M^AQ,BW-@A`8F/\%HUMYR&6Z#))[A)?;NG&L?CW&2L53%9*V*U:[!`'RIA]#( M@Z&-`4AA=,E44%3HP*%B&:[QP[C%GCL)NA:Q-/FGA\D22"H)AD`Y=E3HS MO-H&+CCB3".\<3QW>+_!08Q[@3M);G%4&D,5QAMIVB15`U-XBAFH@2&<.=8J M_3)-A%/5&#F$C"'5AL'#47!'P(?1`^F#E5\;+V*WNQ+!E7NIW>]@N"(!):QK MYB(=%."#+E4<*&@RJ`'8*@TO1K\.!Z#" M^O18Z`!O2)#@ ML>-VY&\?LTGRP.VMZ;ZC/]ESI=3AHI51F*`Y2MIVO0'JL_TE; M6CT!DA>/7*Y\&%^1;L#98XP"TC\K@@Z=/"R_TP"ILGONH#&LR$3K6[<1BZB# M$%@L*&&2AQV0PHU+S[GV?"_Q<$PHRW93GJ?1A=CA:CX1SUQ@,T7TSZOWR:7`Z&L_GW:#"\&/5'"W!< M-5MMUBFTQ$>#=6>U-$3.-5N!YM@&@U/];9R$:QSUW#N:7:MF1DXI;76Q6@^Y MM'XM%P7#(ST^\6QE*HV<3!P&A?+5TJGS0!>\S!:[J\)M+'/+`WFEFO4&V16%IC-#23ZD$EG0YL'071W[_[\>ST M])\H2@LASTG\"(:8T1:[XDBOKA:5O&4*ZF%7>"<7AD0V+4()PZA\L?X-@TOC M,,%FPZ-4TB9_-%!YYDC$P'!&C:W*%B8):SSDP5>Z5M^)8V_E8=><0K4EM$4M M0]-4E*M1!TE%,\PRBCZ'X=)XG&Q[@#0;&5L>$FMG68T'Q/)&#TX-!FT:3[A" MF6)M-JGZ#*91&T^<`IXHY4Y>?W'\K6J'M"AF=1I+`;(T?U61`<,6!3!AQBH] MR!ZG!]E/3TXZ)^G_49P>:G>VR6T8>7]BMX/^=O+JY.24#FKHCI;906_?=,[/ MWW9>O_T!A;O3[^@%>?[F[!^=\S=GR*-9H%RVS?6'MR>='\[21W2X?,F>OGG; M.7][WGG]YA2]('__>/)CY_SLG-<[%?0R<)Q,^#2'[Q\1GKHN.QCI^%/'ES:7K+REIQJ,311M,LS<$)YL]5I@>&<,5;^AATG"X)[H=AC[)VT[ M?&:.'JRX08E//(^_$V1AY]M_PB).W;+_GKL%8&W4V&>#!BS"&:*5AZV<,O/" M>'4TJ&?C"942@X_/?5:/$?&+T$%Z=,G6@2L30C M+@M9ICABF;7J(QRU9DOQ8ITIBA!2I0;&O3''J@\TBQ`2'`G37&Z](NJMKPA1 MHR72J:`KR%85AT@R!48]N793%MD\`5"2J?-`FJFT2C-%#D@3>;A$J\__6&8: M/^<%FFHL%;MQ7Y9+MTJP,F0MMU)1N+0JX=,S*IO1/`R9%'<'2O%)\I34"5N[ M);`6<'$UH%*R=7(8P5-P(TLSRTUZP]D.D:9>*9(#UBP.*J7M)[U10A;3W@BB MK;/)#)^89H)*HUTF1V@Y&^>.3S/XW.%@B]5'!04IJ[., MUAK^.AV.YU#8U`_C9++*O@&E^U:2L>L$2^"575].``P[9*A$5R9FF8-CV@G! M(,,,QYC4V&TO<`<$NQ^R@\X9PY7K>UH=NVNI!O#+RZ@:!3!D,D$IYO1+==@: MA+O3@L&S.?9)F3C9/2!C:$;Y6$R-$ABFF2*M\FZR^#2:9(J\RC M>HBNGN`D\8O;:4@' M)TZ*IU*YCP6#(,JNN&G7#62`;#0PPO+9ZV#*?7>BA0K/#0U!<0LGM8Y[1<8J MAV3P2KSA!8!Q10)-ML!"/7489,@/*N3;]SXXL;=46*>0M4D.+5R>)%)!,/Z. M#EV5+Q]Z\U&?,0:1J`[-/_5FPR?:&?(5>S>W9%1U[DC'=8/'V_4UCB:K;-M" MS::UO4JPMH=D/].*C27-U%OGV?Z8J^S[.AQ]_+08#KJ]+\-9[^,0C:\^?R`T MG%P@$NY]GHQ30L[1Y&HQ7_3&@]'X(XR>C;OKDMX^=N&'W^H6C_4J+=U&J@2O MN(54D&^=C0U`:F\=I4J(:8';N4)O+"/HIE%XY[G8_?!P%6-W%!0>8&^9>'?I M(9N:&:\]"K+LG>UI:,6%:U@*&!+O#5U8$>_-/Z&+R\G7\ISM^"/J]1>C+RP% MZ;N6#D\U],'M'I&J:1T)+L$%QPGRB0",OJ/G_G<;)[23BQ?A#-/F\=@=B#M+ M%N%A>I>G>97='`5/5UGE!`>'?P^8K^0)C1-3*Q2O0DE(KUU,7T8O.F/?('U* M_U[2P7U+WH+HE&XQ<^(4+]+VA?:^5OXV#T7UED5L?ATR<#RK^=_!L%$"JLJB M`;@K3O*P';LDGJ*3>SI"J(2M1A1:P*580BH)ABY:>+K3-?GAFE48(=+-;9S@ M87<-IQ^[5`VD M`PJ6$29][`"G_^95Y[\9+[VMJ2J;9+6+4Q>JJ*>M`RVS3`K+RY("HD MH9(Q#;(7SCW>AX\*[78IJ35)STJI*GQBZF"+QU-66])1/@=FIO?0>\HS`#4Z M;;-0@%_'O4(!\'@MHA3WL*420%+-BR9,(TP3JP[P"M,@.]]6'+@3NB=3>Z'G MOH6U2\4F!NLY:E(28/(V@%]E=:8*[/"+:&+UCCCCNA$5VR6MRA`]0:M:\,=N M!>)GC#BFHH99D%-I@2??'+`S^,N0*DUE>N_FE2$H-HZ M`17&U'*PHOA?/H;3Q0]U<];E\5N'WSS7#+=O34[B``35T: MP\6'V"JH+0@`E0T,-:"TIA0PT=#>T.NV"H[&7X;S)EL%[;&;N#79OJ+>\H^M M%^'/SO+6"W#T0&(^FJV<)6915)BILDT6-S.(9ZZ9)K05SD:HA9"=`+HE_@5= MVL2Y+`QBFG^,C_Z:H7:SC^M>GX7'H,8M]*F\M^#E:L_%6[CP`B=8'L!;T!8$ M@,8&AAK065,*=&^A'GJ=MW`Q&O?&?9C>0A0N,7;C"T*%W>XH+DVR:I"JU[/J M(YB:47(/ZI3`,-,4J7:O&MTJ\BW;[E;:B4DX#X^,_+W0!K52%F^+>C+0*L;Q MLB"))@$H+A"EXHA6"4IN<9H;G=09RS1Z&T9)-\'1&@7PKI'G3>4N'G_0I"32 MJ[1%.A5X%?&J\B#)IP#9C("E2^"K=(3%QAG>9&'?9&70]:G%[2;`U8,NY[Z5 MRT*+OFMPBCN+ZU<4T107I%*PFE:\%7LHPKY0&,U#70I1E7!J-^[-A;SY$+P;#]*^7 MY!FBL7)+1V:H&:H6L'RB?L-J026<=>@OT8?AQ-![3V8;)!4U8 M-)H,(%;PZQ8J>!AHQ_X2+E7U#L<#LXJU>!1VN]FD)YHS(4L/ ME4]#DG[V8C+[S/)1PV!LGO-SZGBJ2Q'+(FTD7N7!R;*NTM_!L$@"2KK@PC;T MTFD_+U.`0HCB-(>6$Q4I^[?6"1#%V^H*$4#DD.&JXP>[JRZA2C`XDG>.8])6 MY,_=2F/@2H*>@11G4I[A]?K.U@XA"54/7''E,F&)X?R!`A?)F,NVPP MY;;]$"]0MJSW]#?&IG?9LGP%^3GV-)M?OIF>WI*CW8]^D!+;N'OV$:;++JC= MH[C6F7XX&\SS6O#I$MA\47X<([U0">1&>;IF,`K(5[VER/-IBFPK=>XK*7H1 M0UV[::4:F%/.-V6@V#JK]T&KVB:?^[6$I71*DR8WXU9[T+7C4^X^43_-5@P6 M83;8.'Z1/56U.`+>80*A6JNSN<@3C''[:Q M%^`X'N!X&7D;-G,0N#2M>3Q934DUTOD%^G2![Y,/OGIGSSX%V>P*]S>4[Q>; ME](ZA1\-7QWC/[;T]N4[=B*DAIL:>;MK-S6PRZLU"F$P M+*M#*'"JD$>I`@PRT?C>2_-`$W>!],IT8@P39Q8WZ/V:%F)U9G0O`TOSH(U* M`$/0O6"+TS^<6DO[!=)D-'V:!EA^H*\D`.C2`SDN88:"2750)M=6)2^7V_66 M#9Q\4F_RMX^S6**W#J/$^Y,]GT;T('?R,"6F)'4'+@]5-J2F/;1)DGFK_`6( M?T,'%>]@\ZS\6SHH?P_YB[ZIPT2&)@<^GY!:2N/'6+4K72D/B`)&,"4[T_D& M*K=/!Q'55CM9=>\*J.(K@.3]:4O5R.5MT0Q8HA2@ZM6`$RZVWXFV/7ZQ9:_; MT'=Q%-,/*GF0AA6"%*"*UX`3KU_;B7Z/4F'42Y+(N]XF;$$C"1$)@-MK#XX: MI&\T:YTZ'4!M90Q5\\D4G7^BS0_ZA(U4Y/')TC]*^W]!"%`SJ+%5ZUVX\[FM M$6*/^]OAU+<*F?+R=H,+MI^PK@]T[3F<^J_'**Y1[C10JH)>9$HO6_L$GC!U M/IS&:@17_()2)?0B5W])$Z(4^2=G1DG+K3;BP9/-0VY*/6+#ULR^1U8*Q!8] M4.)AR.VH!&O8A$4RXIY!,N)6^M1'I>V%W'0JK$V[TFG]#D7;#7>H=+?`FT\% MU[P%V=Z^2[-;NI[2T;25'19.@^X!6G;2G)TNF7(GS5]2^2$&4%H*($$,L1UO(RPFG3/4`W_%:+HMK_5@^2 M?@9.V]5"U.>>2?9P_(O^X)JX4 M>?+_4$L#!!0````(`"XP/D!&NLZVNPT``!C'```5`!P`;F%N;2TR,#$Q,#DS M,%]P&UL550)``.(>"9/B'@F3W5X"P`!!"4.```$.0$``.U=67/;.!)^ MWZK]#US/R^Z#+#N9RZEDIQ0?*=4XMM=R9F:?4A#9DK!#`0I`^IA?OP`ERI1( MD$V*#"!7\I`H4C?8_7TX&E?S[2^/\]"[!R$I9^\.C@^/#CQ@/@\HF[X[^#3J M#4:GP^&!)R/"`A)R!N\.&#_XY=]__YNG_KS]1Z_G_>>/(8M`$#^B]^#U>NJW MMR%E?[[1?XV)!$\]@\DWCY*^.YA%T>)-O__P\'#X\/J0BVG_U='1$8)_;]>*M;37_6.7_5>'Q\^RN`@139!4/`0;F'BZ7\_ MW0[73V5S.@,21K-#G\_[^M?^&??C.;!HP()S%M'H:<@F7,P3:Y4'27$S`1/% M'V%S]=3CXZ.3UT?ZF=]A=*.GA>)>TODB5(CTFYKYGH0:T]$,())5=A4*=V'( M#1'*_1E$U"=A+:L*-5LR<121"#0O\GIRO5`M3/-1"5JY5@>FG1(YNPCY0RW+ MJI']J,9W;ZGN9?579J>&A]S? ML#74XR$750!=#:X^?BZS!\#TN M`A"*KK10(OR-6I"/*582_44R'O7\&0W7%6@B^+PNEBO<>)4G67R5#5^=A%/E MB2#A4#68QU_AJ92%G"R2AF,'>3#X;8.(U)$[56Q%^UV*(&%_Y13L15[:1/L& M!.7*A>!,!545L&_)(O%_[23^A7[;(&*@K`FT1165WRR.I.$'IVBH\M[>$/P[A.&OC#^P$1#)&01#*6,0 MI4.Q40?)S8].<8/"P1Y!O_$P5A"*IPL:@I"EQ.1DD83\Y"`A!K\M!JO+-GP+ M"R[TA%$OB,3E?)A4D+3\["`MY2C88R>I):>J2YUR43Z1V))$%/MNC MX"8>A]2_"#DQK004R*%G<0[B7^"PQ>Z)S^>NE\9?>3UOO4>E/J_$O:6\]\]/C,0!C2#X M5Z-E\6R-FA`Y3LB)96]*R&)9K2",9/K-=OU:??UY;>#UY((R91]5U9]+BEA% MQZGNW%J:^S:04@%=X<6VD,VU]#ID;*RI%#K:9I>U*PFK(!W%14[6Z@+O;IP8 M_':#&KUI;EKM2GZRNK);#B#?MM4E8`>^SV,6R5OP@=Z3<0A7$*T\,57]4A6K M*[UH(C!NNT'0D*E!'.[((V2,-3!CD+6ZZHNFI-11-[BX$;`@-#A_7`"3H,+$ MZV@&8L-#`S,H3:LKP&B>:H#@!FM#IH_);?<`!S3 M()I5_6X6=?&C1D4E5U9/0/T87"Z=-=J6&!;QB(2)I.5.C2]`1$\W:LJ73'V_ MQ'2AHTA5KRJ"8)RJU47B&MT:'@8WFIG1X@^"2]/22Y62W27E6B1@R-N`P@W: M5.@9S^-03=6",U#PJEF:!E=]#B%!F06#N=X?^BOYWNB:.3IOJ7B[J]=-JT+; M\-;OWD^6W3N#J3;"[0Z^0<=N>]V\]3ZB.'[:R[%\.=J5AEQX^KJ9HC=NUQNN M[3M1EY2,:4@C"E)AD.RRS7BH<)<:C^BI(O#"JV/)[F92V93LNO"X,;)GK,8M M(I] M(4]Z^0^W$+TMC-Z$<8"5=).46DNCZAHB,CSB*#*I8PKJ9:>Q$6"D8SM`G M8A4>Y=PT1?FZARM]U@YXI'@.ON"B6QC'2S\5F/D1)7W>-BJV&' M1$HZH1#@.:HL`I?LR\F=^K0?:W8OEZ+O`5NEB-W)*GCV\DMLI3D1D$WHE3:ZAV.';G9]'A7 M6@PY%@N?6G)7ID3>ZCV,%K"NN#CSU8/SBKR\Z\#\^ZW`_%G/XQ/O6=.1^\C+ M"TMK(ROB5Z.TS2"FR&\R<JF,UH*W%"\IY-W@:0:C*G'X`IOP+]76*8$Y9DAI9OP:C MG#"LLM5PMQ9S]>!P@\*<@]A!QW)L7(L8HY/[OJVQ=FPY]EZ:+_L52EJ]:MN, MP;RC;K2C*\[XIHWIK?CR8`ZA9_<>9BV:T"BX0=H'0IG4=0GD-3M_U%;'5,Z6 M2_AG,#:1AM"S>V,2SP.OY95+Y"7OVP)9$1;FI.S>6&Q$C,'3_;^.:D2C;F=I M.UU@(UHKO=_WZ.0*HLJX9$L&2V,WT7XS&HN\W'?JTJ-9Z8ZD?CV8;Z#0(&OW MNFDC*DN][FBSXG>@TYGJC@W^JZ/#=7,9MK4)`C)Y:,)&Z-=0V!`FEUWB*PV^(5#AG8X,RY@S"=O-/OR5."Q'R@TVDW-(S(?K27(X:<"" MWXG0+T^5%UR,0-Q37\7NXC0D=&X:E&N683?-\5?BOA&N;E0)^POO'65._DK4 M-UFJW],U8H6<`-7!G<'RWPQ6JUN>U:?MT`783??\M?J-VHBZT6GD[LET)3B"K-[7*-MKNL`Z&HEV,Y1B28\KVCW MR$?;Y)J`>8E]^%:&Q=K1W5K/[O&0KF*[+5A>:`W82MU8IQ+D5.TF/.^@'AC` MV?^J@-_;V'DOUO:QH]VJ17V@]OUPDL%C'>'*-K;K2PO"5I5NUH@ZJ2H(X-R( M$M5XMUH>&_A?8BK@(U%8,1!/B+?A8)4MGXUJ3A&O[^M+623&H[9S3V`[TW\[ M%:0^8"]TT%@E:MI]T"@MR&Y6^TZK#`)`1P8/P7V`0%XH;)ZW3C-9,TSC1K6> MW5SX.Q##:[GI*IO9A.0($C?%[6;-;Y^[(C#2:2^M(*=>?,@;%T%"\687+/BH3I/:LAFW`Q)Y@$WEAM+/DN MQ\,UH7*C/TT3-.B7CQBW)[,B6*8ZRN%:$^."5!193UWA8'V^K92&+2DL$QUE M>-V%B4)_W2`C]>6*,U]]?%YI9$%!?W!&I1]R&8NJ9$F[%XNENZ.W3#6GNRU$ MNT^YO$SQG%Q!B:(P<[LX/;"D$^.ASO7L6BB6[&XV:EICK#C'\PXPN]%'Z!6N M(5.^QMKV=,*T.M*2CC.&FH'415\!W)L*4`LT%Y)?Z!0J\GIRDRES;=XZ]<6/ M7L][]C]Y#X_2\JXGWH9>B_U5LF9WQ]>O:7E.ME&9KZ]:T6*C>A]+RD#*,Y"^ MH(NDHK.@@(0[1>3[T+SKU:0@FYDL\(1FFU-SN%QH6Q^X/O:C>A<0!8WJI^U& ME8A[J?RWQH1X:=R7F`8T>GJ&L:K9E*OL7P/!0.!"4QC1*:,3ZA,6W0G"I'*G M^,42/V^WBHRFMZ'ZK8$@M@2?-RRSV.';2ZT2]J_Y-`#(B=84CR5\B55YY_K2 M6$$S.LDUH[6*M]+YUGX0Z\*;.%>UEA+Y_6L;E1NH7L7V-I!E.M%K3Z1?\U)A+4-_\'4$L# M!!0````(`"XP/D#^;R8#P@0``(4<```1`!P`;F%N;2TR,#$Q,#DS,"YX"9/=7@+``$$)0X```0Y`0``[5G?;]LV$'[>@/T/G)ZV!UEV MO&9U8+=PDZ8PD,9MG6!]*VCI9!.52)>DG.2_WY&2K!^VE-A-,&!)'PJ9]]W' MNX]'2KP,W][&$5F#5$SPD=/K=!T"W!>FWQ%RX1UUNSWO MZ\>+F<4Y*?#D-F+\^RYX;S`8>-::0[>0MW,9Y=1]SYCG5,&&&:VL!<^XTI3[ M%7R@-PYE\"LO-5:@;"?T.(6R'!I`#:?`[RS$VD,#XGL]M]MS^[TEJ MXQ)2-;?4F6&'R^7X\N,&SV.V!!KI9<<7L05W!WVSHA'$P/6YD/$9A#2),-$? M"8U8R"!PB*9R`?J2QJ!6U(?[Z/)2H)P+33463C9BQE8KQD.!`[\,S9*<2!'! MU=T*B'FX_C)I(#=6[TSXB8ESS(/W7#-]-T$J&=LI',*"D=.*,)-B"';:`$+& MF8VMBY5'7)*[EA\I#TC*0TI$0Z].42).%`13_L8^KR0HI+%.%SB0.6:0!B>? M1GX2[>=3A++3)1O(I3Y,_'1N-FA>F%J%OU5J^B&@5B*%]'?4<50 MU$^EG/+39=O0+/BQ>3\RY4=")1+LN8+N9!J2,L'SE/B#P*_B4X&GK,RTK8PT MB_IW753K1S+'YRGFC"TX?G_ZE.LK2;DRMXGB<&XP-DO\NBYQB8*4.9ZIVLE< MP8\$\WF_-J=G)G-]M%G?P9:^&U^2.C]/87$/:]S+>&=FD*E:'6J4M->M2UIQ M_/_(:?XS5_,O$!)[I3_1:!\YBL6KR%S`[=A20CAR..6QF]\TOV%J';SFYA!# MW7*EM^M15R.;.*>@TM]BV6HY((G`SSF-JU#N*Z2A,VW(^6( MSO=-&5T@>L)<+PS_HR:)U;=ODK6"?:)43XM9'C5AW#K[)ES=;4^4[]EFDG*Z M62_'*YHYV>]ZPV>(B0NI"=]J';4UW-)6X87P+56+B_GEYGZN&7)[1VZ_U[E5 M01'I/D$4,NP71.YW0!#E'IXI%U5IXC6$84/8V?WS(-)JP^467`^-I[4-V19. MW<<\'#!_:T_S<#G,R`'15-8[T-(SLGI<<)K"D"6?"S:((7?X-"(?#3$R=-#/*#%,DJ M!^+U/VY+\53$L>`S+?SOLR7%5_A$J<1$E.?5!K@W^/2DTK784YJ?C_T?8(NE MAH"N0=(%8)7-04[#+&([RS31)@+SMYL\H;V]#EVBQTJSM`)&>PC.A9R!UBDN M;1J-@[5Y(RBLOK'OBX2;KNE=PSH>QK*'#*EMGK9?1XXO(6"U(L!80%-Y]PCZ M7`H-ZDJ<,_S`\!F-BH98?8\^!/D?[M"AEYYG^/@O4$L!`AX#%`````@`+C`^ M0)?@S#[?%P``^K@``!$`&````````0```*2!`````&YA;FTM,C`Q,3`Y,S`N M>&UL550%``.(>"9/=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`+C`^0.'P M53XH"```4F$``!4`&````````0```*2!*A@``&YA;FTM,C`Q,3`Y,S!?8V%L M+GAM;%54!0`#B'@F3W5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`"XP/D`* MOYW-"`,``$@2```5`!@```````$```"D@:$@``!N86YM+3(P,3$P.3,P7V1E M9BYX;6Q55`4``XAX)D]U>`L``00E#@``!#D!``!02P$"'@,4````"``N,#Y` M1JW4[NL5```_(P$`%0`8```````!````I('X(P``;F%N;2TR,#$Q,#DS,%]L M86(N>&UL550%``.(>"9/=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`+C`^ M0$:ZSK:[#0``&,<``!4`&````````0```*2!,CH``&YA;FTM,C`Q,3`Y,S!? M<')E+GAM;%54!0`#B'@F3W5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`"XP M/D#^;R8#P@0``(4<```1`!@```````$```"D@3Q(``!N86YM+3(P,3$P.3,P M+GAS9%54!0`#B'@F3W5X"P`!!"4.```$.0$``%!+!08`````!@`&`!H"``!) %30`````` ` end XML 24 R5.htm IDEA: XBRL DOCUMENT

Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
Statements of Cash Flows (Unaudited) (USD $)	Sep. 30, 2011	Sep. 30, 2010
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (320,792)	$ (603,888)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	146	130
Common stock issued for company expenses incurred	12,170	27,737
Common stock issued for services	331,200	83,850
Gain on settlement of vendor liabilities	(372,949)	(14,754)
Changes in operating assets and liabilities:
Accounts receivable	(650)	0
Refund receivable	2,500	(2,500)
Inventory	(59,983)	632
Prepaid expenses	571	696
Customer advances	70,130	0
Accounts payable	292,216	31,278
Accrued expenses	(2,834)	341,719
Net cash used in operating activities	(48,275)	(135,100)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of equipment	(4,700)	(973)
Cash used in investing activities	(4,700)	(973)
CASH FLOWS FROM FINANCING ACTIVITIES:
Common stock and warrants issued for cash	30,000	0
Proceeds from the issuance of short-term notes payable	0	6,855
Proceeds from the issuance of related party short-term note payable	25,000	0
Repayments of short-term notes payable	0	(6,855)
Net cash provided by financing activities	55,000	0
NET INCREASE (DECREASE) IN CASH	2,025	(136,073)
CASH AT BEGINNING OF PERIOD	2,810	136,908
CASH AT END OF PERIOD	4,835	835
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid for interest	0	0
Cash paid for income taxes	0	0
NON-CASH INVESTING AND FINANCING ACTIVITIES
Common stock issued for settlement of cash advances and accounts payable	153,000	10,000
Accrued interest added to note payable balance	$ 0	$ 12,620

XML 25 R10.htm IDEA: XBRL DOCUMENT

Contingencies

9 Months Ended

Sep. 30, 2011

Notes to Financial Statements

Contingencies

NOTE 5 – CONTINGENCIES

- Definition

The entire disclosure for commitments and contingencies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14435-108349

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Interpretation (FIN)

-Number 14

-Paragraph 3

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 440

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 5

-Paragraph 9, 10, 11, 12

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

+ Details

XML 26 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 9 80 1 false 0 0 false 3 false false R1.htm 0001 - Document - Document and Entity Information Sheet http://nmihealth.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 0002 - Statement - Balance Sheets (Unaudited) Sheet http://nmihealth.com/role/BalanceSheets Balance Sheets (Unaudited) false false R3.htm 0003 - Statement - Balance Sheets (Parenthetical) Sheet http://nmihealth.com/role/BalanceSheetsParenthetical Balance Sheets (Parenthetical) false false R4.htm 0004 - Statement - Statements of Operations (Unaudited) Sheet http://nmihealth.com/role/StatementsOfOperations Statements of Operations (Unaudited) false false R5.htm 0005 - Statement - Statements of Cash Flows (Unaudited) Sheet http://nmihealth.com/role/StatementsOfCashFlows Statements of Cash Flows (Unaudited) false false R6.htm 0006 - Disclosure - Basis Of Presentation Sheet http://nmihealth.com/role/BasisOfPresentation Basis Of Presentation false false R7.htm 0007 - Disclosure - Going Concern Sheet http://nmihealth.com/role/GoingConcern Going Concern false false R8.htm 0008 - Disclosure - Significant Transactions Sheet http://nmihealth.com/role/SignificantTransactions Significant Transactions false false R9.htm 0009 - Disclosure - Subsequent Events Sheet http://nmihealth.com/role/SubsequentEvents Subsequent Events false false R10.htm 0010 - Disclosure - Contingencies Sheet http://nmihealth.com/role/Contingencies Contingencies false false All Reports Book All Reports Process Flow-Through: 0002 - Statement - Balance Sheets (Unaudited) Process Flow-Through: Removing column 'Sep. 30, 2010' Process Flow-Through: Removing column 'Dec. 31, 2009' Process Flow-Through: 0003 - Statement - Balance Sheets (Parenthetical) Process Flow-Through: 0004 - Statement - Statements of Operations (Unaudited) Process Flow-Through: 0005 - Statement - Statements of Cash Flows (Unaudited) nanm-20110930.xml nanm-20110930.xsd nanm-20110930_cal.xml nanm-20110930_def.xml nanm-20110930_lab.xml nanm-20110930_pre.xml true true